DekaBank Deutsche Girozentrale lessened its holdings in shares of MAXIMUS, Inc. (NYSE:MMS) by 34.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 122,200 shares of the health services provider’s stock after selling 64,100 shares during the period. DekaBank Deutsche Girozentrale’s holdings in MAXIMUS were worth $8,071,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also modified their holdings of the stock. Wells Fargo & Company MN increased its stake in shares of MAXIMUS by 4.4% during the first quarter. Wells Fargo & Company MN now owns 653,828 shares of the health services provider’s stock worth $46,409,000 after purchasing an additional 27,504 shares in the last quarter. PNC Financial Services Group Inc. increased its stake in shares of MAXIMUS by 1,182.3% during the first quarter. PNC Financial Services Group Inc. now owns 68,077 shares of the health services provider’s stock worth $4,833,000 after purchasing an additional 62,768 shares in the last quarter. Advisor Group Inc. increased its stake in shares of MAXIMUS by 117.4% during the first quarter. Advisor Group Inc. now owns 1,889 shares of the health services provider’s stock worth $134,000 after purchasing an additional 1,020 shares in the last quarter. Parametric Portfolio Associates LLC increased its stake in shares of MAXIMUS by 13.2% during the first quarter. Parametric Portfolio Associates LLC now owns 189,730 shares of the health services provider’s stock worth $13,467,000 after purchasing an additional 22,184 shares in the last quarter. Finally, First Trust Advisors LP increased its stake in shares of MAXIMUS by 76.1% during the first quarter. First Trust Advisors LP now owns 72,406 shares of the health services provider’s stock worth $5,139,000 after purchasing an additional 31,295 shares in the last quarter. 94.37% of the stock is owned by hedge funds and other institutional investors.

A number of research firms have recently commented on MMS. Zacks Investment Research raised shares of MAXIMUS from a “hold” rating to a “buy” rating and set a $75.00 target price for the company in a research note on Monday, May 27th. ValuEngine cut shares of MAXIMUS from a “buy” rating to a “hold” rating in a research note on Thursday, February 28th.

In related news, Director Russell A. Beliveau sold 1,000 shares of the business’s stock in a transaction dated Monday, April 1st. The shares were sold at an average price of $71.40, for a total transaction of $71,400.00. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Vice Chairman Richard A. Montoni sold 12,000 shares of the business’s stock in a transaction dated Tuesday, March 12th. The stock was sold at an average price of $70.69, for a total transaction of $848,280.00. Following the transaction, the insider now owns 412,874 shares in the company, valued at $29,186,063.06. The disclosure for this sale can be found here. Insiders have sold 48,000 shares of company stock worth $3,403,630 over the last 90 days. 2.20% of the stock is currently owned by company insiders.

MMS stock opened at $71.25 on Monday. The stock has a market cap of $4.55 billion, a PE ratio of 19.96, a P/E/G ratio of 1.92 and a beta of 0.92. The company has a debt-to-equity ratio of 0.06, a current ratio of 2.31 and a quick ratio of 2.31. MAXIMUS, Inc. has a 52 week low of $60.00 and a 52 week high of $74.18.

MAXIMUS (NYSE:MMS) last released its earnings results on Thursday, May 9th. The health services provider reported $0.96 EPS for the quarter, topping analysts’ consensus estimates of $0.91 by $0.05. The business had revenue of $736.50 million during the quarter, compared to analysts’ expectations of $757.29 million. MAXIMUS had a net margin of 8.76% and a return on equity of 21.19%. The company’s quarterly revenue was up 20.2% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.84 earnings per share. As a group, equities analysts anticipate that MAXIMUS, Inc. will post 3.7 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Friday, May 31st. Investors of record on Wednesday, May 15th were given a dividend of $0.25 per share. The ex-dividend date was Tuesday, May 14th. This represents a $1.00 dividend on an annualized basis and a yield of 1.40%. MAXIMUS’s payout ratio is presently 29.41%.

COPYRIGHT VIOLATION WARNING: “DekaBank Deutsche Girozentrale Sells 64,100 Shares of MAXIMUS, Inc. (MMS)” was first reported by Watch List News and is the property of of Watch List News. If you are accessing this news story on another domain, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The original version of this news story can be accessed at https://www.watchlistnews.com/dekabank-deutsche-girozentrale-sells-64100-shares-of-maximus-inc-mms/3029975.html.

MAXIMUS Company Profile

MAXIMUS, Inc provides business process services (BPS) to government health and human services programs worldwide. The company's Health Services segment offers various BPS, appeals, and assessments for state, provincial, and national government programs, including Medicaid, Children's Health Insurance Program, Affordable Care Act, Health Insurance British Columbia, Health Assessment Advisory Service contract, and Preadmission Screening and Resident Reviews.

Recommended Story: Bond

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MAXIMUS, Inc. (NYSE:MMS).

Institutional Ownership by Quarter for MAXIMUS (NYSE:MMS)

Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.